HomeAI · summaries
Storia in 3 fonti
1.8B Deal Puts Samsung Biologics Ahead in CDMO Race
Samsung Biologics proposed acquisition marks a decisive move to consolidate its position as a global contract development and manufacturing organization
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
asiabusinessoutlook.com
1.8B Deal Puts Samsung Biologics Ahead in CDMO Race
Samsung Biologics proposed acquisition marks a decisive move to consolidate its position as a global contract development and manufacturing organization
- ·
fiercepharma.com
Samsung Biologics spreads wings with proposed $1.8B acquisition of Swiss CDMO PolyPeptide
South Korean contract manufacturer Samsung Biologics hopes to tap into the booming peptide production and weight loss market with plans to buy out Switzerland-based CDMO…
